​

Funding Round

Series A - Crossbow Therapeutics

Series A - Crossbow Therapeutics

Investment Firm

Overview

Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.

Announced Date

Jul 11, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Pfizer Venture Investments

Pfizer Venture Investments

Pfizer Venture Investments is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorBiotechnology Value Fund
Participant InvestorMirae Asset Venture Investment
Participant InvestorMPM Capital
Participant InvestorEli Lilly
Participant InvestorPolaris Partners

Round Details and Background

Crossbow Therapeutics raised $80000000 on 2023-07-11 in Series A

Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 11, 2023
Series A - Crossbow Therapeutics
7-80.0M

Recent Activity

There is no recent news or activity for this profile.